0001103021-22-000029.txt : 20220208
0001103021-22-000029.hdr.sgml : 20220208
20220208205505
ACCESSION NUMBER: 0001103021-22-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220204
FILED AS OF DATE: 20220208
DATE AS OF CHANGE: 20220208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vollins James
CENTRAL INDEX KEY: 0001757833
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31361
FILM NUMBER: 22603530
MAIL ADDRESS:
STREET 1: C/O BIODELIVERY SCIENCES INTERNATIONAL
STREET 2: 4131 PARK LAKE AVE SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC
CENTRAL INDEX KEY: 0001103021
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 352089858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 919 582 9050
MAIL ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
FORMER COMPANY:
FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP
DATE OF NAME CHANGE: 20000111
4
1
wf-form4_164437168992570.xml
FORM 4
X0306
4
2022-02-04
0
0001103021
BIODELIVERY SCIENCES INTERNATIONAL INC
BDSI
0001757833
Vollins James
C/O BIODELIVERY SCIENCES INTL, INC.
4131 PARKLAKE AVE. SUITE 225
RALEIGH
NC
27612
0
1
0
0
See Remarks
Common Stock
2022-02-04
4
S
0
18541
3.60
D
9872
D
Common Stock
2022-02-04
4
F
0
9872
3.66
D
0
D
The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan.
The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to vesting Restricted Stock Units.
General Counsel, Chief Compliance Officer & Corporate Secretary
/s/ James Vollins
2022-02-08